首页> 外国专利> Prodrugs of non-steroidal anti-inflammatory agents (NSAIDs)

Prodrugs of non-steroidal anti-inflammatory agents (NSAIDs)

机译:非甾体抗炎药(NSAIDs)的前药

摘要

Compound of formula (I): ** Formula ** in which: R1 represents a unit that promotes the selected immobility of an organic moiety with a molecular weight of less than 1000 g / mol comprising one or more nitrogen-containing moieties each with a pKa between 4 and 7.6 at 37 ° C; and R1 is phenylamino, imidazolyl, isoquinolinyl, quinolinyl, benzimidazolyl, substituted or unsubstituted acridinyl according to the following structures: ** Formula ** wherein R3 is linear or branched C1-8 alkyl, or alkoxyalkyl, R4 and R5 are each and independently from each other hydrogen, linear or branched C1-8 alkyl, alkoxyalkyl or phenyl; and R3, which is located between the core of IPU and the NSAID, can be attached at any point to the core of IPU, either in a carbon atom or nitrogen in the ring; -O- (C = O) -R2 represents an acyloxy residue of a carboxylic acid group contained within a non-steroidal anti-inflammatory agent (NSAID) selected from the list consisting of: ketorolac, ketoprofen, fenoprofen, oxaprofen, diclofenac, tolmetin, tolfenamic acid, mefenamic acid, sulindac, indomethacin, acetylsalicylic acid, deflunisal, loxoprofen, indoprofen, priprofeno, clidanac, fenclorac, meclofenamate, benoxaprofen, carprofen, isofezolac, aceclofenac, fenbufen, etodólico acid, fleclózico acid, amfenac, mácido efenámico, Bromfenac, flenclofenac, alcofenac, orpanoxin, zomopyraco, flufenamic acid, niflumic acid, pranoprofen, zaltoprofen and suprofen, x is an integer selected from 1, 2, 3 or 4; wherein R1 contains an R3-OH group, which together with the NSAID carboxylic function forms the ester bond, and in which R3 is different from -CH2-OH when R3 binds to the nitrogen of R1; and salts, solvates and hydrates thereof.
机译:式(I)的化合物:**式**其中:R1代表一个单元,该单元促进分子量小于1000 g / mol的有机部分的选定固定性,该有机部分包含一个或多个含氮部分,每个部分含一个在37°C下pKa在4至7.6之间;并且R1是根据以下结构的苯氨基,咪唑基,异喹啉基,喹啉基,苯并咪唑基,取代或未取代的a啶基:**式**,其中R3是直链或支链的C1-8烷基或烷氧基烷基,R4和R5分别独立于氢,直链或支链的C 1-8烷基,烷氧基烷基或苯基;位于IPU核心和NSAID之间的R3可以在环的碳原子或氮原子的任何位置连接到IPU的核心; -O-(C> = O)-R2表示非甾体抗炎药(NSAID)中包含的羧酸基团的酰氧基残基,所述非甾体抗炎药选自:酮咯酸,酮洛芬,芬诺洛芬,奥沙洛芬,双氯芬酸,托美汀,甲苯磺酸,甲芬那酸,舒林酸,吲哚美辛,乙酰水杨酸,去氟尼,洛索洛芬,吲哚洛芬,普洛芬诺,克林达那,芬氯拉芬,甲氯芬那酸酯,贝诺沙芬,卡洛芬,异氟唑酸,醋氯芬酸,醋氯芬酸,醋氯芬酸,醋氯芬酸溴芬酸,氟氯芬酸,铝芬芬,奥拉帕辛,苯并吡喃,氟芬那酸,尼氟酸,普洛洛芬,扎托洛芬和舒普洛芬,x是选自1、2、3或4的整数;其中R1含有一个R3-OH基团,它与NSAID的羧基官能团一起形成酯键,并且当R3结合到R1的氮上时,R3不同于-CH2-OH。及其盐,溶剂化物和水合物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号